SCHEMBL16943552

SCHEMBL16943552

Cn1ccc2c(c1=O)c1ccc(Nc3ccc(F)c(F)c3)nc1n2C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.38
APP P05067 3/20 0.37
MAOB P27338 2/20 0.34
P2RX7 Q99572 1/20 0.34
TRPA1 O75762 1/20 0.33
MAPT P10636 3/20 0.33
EGFR P00533 2/20 0.33
PDGFRB P09619 1/20 0.33
FGFR1 P11362 1/20 0.33
SRC P12931 1/20 0.33
PDGFRA P16234 1/20 0.33
STAT5A P42229 1/20 0.33
ACVR1 Q04771 1/20 0.33
PKMYT1 Q99640 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HSD17B10 Q99714 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21088595 0.76 DHFR (0.46) DHFRAPPMAOBMAPTKDM4E
SCHEMBL18354324 0.75 DHFR (0.40) DHFRAPPMAOBTRPA1MAPT
SCHEMBL16943529 0.75 DHFR (0.40) DHFRAPPMAOBTRPA1MAPT
SCHEMBL16943119 0.70 BRD9 (0.33) MAPTSMN1; SMN2
SCHEMBL18354313 0.70 APP (0.38) DHFRAPPTRPA1MAPTKDM4E
SCHEMBL16943265 0.70 APP (0.42) DHFRAPP
SCHEMBL16942999 0.70 APP (0.38) DHFRAPPTRPA1MAPTKDM4E
SCHEMBL22011320 0.68 APP (0.35) DHFRAPPMAPTPGRBCDIN3D
SCHEMBL16941567 0.67 APP (0.36) DHFRAPPTRPA1MAPTCYP1A2
SCHEMBL18354308 0.67 APP (0.36) DHFRAPPTRPA1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662193-B2 Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins AC IMMUNE SA (CH) 2020-05-26 US disclosed
US-20170002005-A1 Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins LIFE MOLECULAR IMAGING LIMITED (GB) 2017-01-05 US disclosed
US-20170002005-A1 Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins LIFE MOLECULAR IMAGING LIMITED (GB) 2017-01-05 US disclosed
WO-2015110263-A1 CARBAZOLE AND CARBOLINE COMPOUNDS FOR USE IN THE DIAGNOSIS, TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH AMYLOID OR AMYOLID-LIKE PROTEINS AC IMMUNE SA (CH) 2015-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662193-B2 Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins APP, BACE1, PSEN1 DHFR 2818/4885APP 1/4885MAOB 483/4885
US-20170002005-A1 Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins APP, BACE1, PSEN1 DHFR 2818/4885APP 1/4885MAOB 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.